CEO
Fagron
Equibles does not estimate personal net worth.
Rafael Padilla is recorded as CEO at Fagron. Rafael Padilla has spoken on 2 earnings calls across 1 company, most recently for Fagron on October 8, 2026. Fagron is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“We're pleased to report another quarter of growth. Revenue reached 281.3 million euros, up 23.2%, or 19.5% at constant exchange rates. Organic growth at CR was 3.4%.”
“We're pleased to report a strong performance with revenues reaching 552 million euro. This reflects 3.1% organic growth at CR, 7% when normalizing the GLP-1 effect.”
Fagron
CEO
Transcript header (unverified)
Fagron
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Fagron Nine Months 2026 Trading Update
Fagron
Fagron H1 2026 Results Call
Fagron
